WF
GILD icon

Wayfinding Financial’s Gilead Sciences GILD Stock Holding History

Wayfinding Financial’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$410K Buy
2,948
+37
+1% +$5.18K 0.18% 84
2025
Q4 		$357K Buy
2,911
+172
+6% +$20.9K 0.15% 92
2025
Q3 		$304K Buy
2,739
+5
+0.2% +$568 0.13% 103
2025
Q2 		$313K Sell
2,734
-131
-5% -$13.9K 0.14% 96
2025
Q1 		$321K Buy
2,865
+283
+11% +$29.2K 0.14% 93
2024
Q4 		$238K Buy
+2,582
New +$232K 0.13% 113
2024
Q1 		– Sell
-2,784
Closed -$225K – 127
2023
Q4 		$225K Sell
2,784
-578
-17% -$45K 0.15% 98
2023
Q3 		$249K Buy
3,362
+219
+7% +$16.8K 0.19% 92
2023
Q2 		$241K Sell
3,143
-121
-4% -$9.65K 0.17% 98
2023
Q1 		$270K Buy
+3,264
New +$270K 0.21% 85

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wayfinding Financial's GILD Position: Q1 2026 in Review

Wayfinding Financial increased its Gilead Sciences (GILD) stake by 1.3% in Q1 2026, buying an estimated $5.18K and bringing the position to 2,948 shares worth $410K. The position accounts for 0.18% of the portfolio, ranked #84.

Wayfinding Financial first reported a position in GILD in Q1 2023 and has held it in 10 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Wayfinding Financial held 2,948 shares of Gilead Sciences worth $410K as of Q1 2026.
  • Wayfinding Financial bought 37 Gilead Sciences shares in Q1 2026, an estimated $5.18K.
  • Gilead Sciences made up 0.18% of Wayfinding Financial's portfolio in Q1 2026, its #84 holding.
  • Wayfinding Financial first reported a position in Gilead Sciences in Q1 2023 and has held it in 10 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Wayfinding Financial's 13F filing for Q1 2026, filed 12 May 2026.